Screener
Sabra Healthcare SBRA Investments in unconsolidated joint ventures
Investments in unconsolidated joint ventures at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireInterestInJointVenture.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Escrow deposits for potential investments | (430) | — |
| Repayments of loans receivable | 1,944 | 1,129 |
| Repayments of preferred equity investments | 1,256 | 813 |
| Investment in unconsolidated joint ventures | — | (1,030) |
| Insurance proceeds | 107 | — |
| Net cash used in investing activities | (105,090) | (16,444) |
| Cash flows from financing activities: | ||
| Net borrowings from (repayments of) revolving credit facility | 137,800 | (23,881) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's investments in unconsolidated joint ventures?
- Sabra Healthcare (SBRA) reported investments in unconsolidated joint ventures of $0 in Q1 2026.
- How has Sabra Healthcare's investments in unconsolidated joint ventures changed year-over-year?
- Sabra Healthcare's investments in unconsolidated joint ventures decreased by 100.0% year-over-year, from $1.03M to $0.
- What does investments in unconsolidated joint ventures mean?
- Represents cash outflows for capital contributions to joint ventures or partnerships with other entities. This metric highlights the company's reliance on collaborative investment structures to share risk and capital requirements.
Ask your AI about Sabra Healthcare's investments in unconsolidated joint ventures.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude